Diffusion limited hypoxia estimated by vascular image analysis: Comparison with pimonidazole staining in human tumors

Radiotherapy and Oncology

Volumn 55, Issue 3, 2000, Pages 325-333

  Haustermans, Karin ^a   Hofland, Iingrid ^a   Van De Pavert, Llja ^a   Geboes, Karel ^b   Varia, Mahesh ^c   Raleigh, James ^c   Begg, Adrian C ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Diffusion limited hypoxia; Pimonidazole; Tumor; Vascular image analysis

Indexed keywords

PIMONIDAZOLE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; HYPOXIA; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; OBSERVER VARIATION; PRIORITY JOURNAL; RECTUM CARCINOMA; STAINING; TUMOR BIOPSY; TUMOR VASCULARIZATION; UTERINE CERVIX CARCINOMA; VALIDATION PROCESS;

ADENOCARCINOMA; BLOOD VESSELS; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; DIFFUSION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; NITROIMIDAZOLES; OBSERVER VARIATION; RADIATION-SENSITIZING AGENTS; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; UTERINE CERVICAL NEOPLASMS;

EID: 0034213645     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(00)00206-1     Document Type: Article

References (33)

1. Awwad H.K., el Naggar M., Mocktar N., Barsoum M. Intercapillary distance measurement as an indicator of hypoxia in carcinoma of the cervix uteri. Int. J. Radiat. Oncol. Biol. Phys. 12:1986;1329-1333.
2. Bernsen H.J.J.A., Rijken P.F.J.W., Oostendorp T., Van der Kogel A.J. Vascularity and perfusion of human glioma xenografts in the nude mouse. Br. J. Cancer. 71:1995;721-726.
3. Brizel D.M., Scully S.P., Harrelson J.M., et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56:1996;941-943.
4. Brizel D.M., Sibley G.S., Prosnitz L.R., Scher R.L., Dewhirst M.W. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 38:1997;285-289.
5. Bussink J., Kaanders J.H., Rijken P.F., Martindale C.A., Van der Kogel A.J. Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts. Br. J. Cancer. 77:1998;57-64.
6. Cline J.M., Rosner G.L., Raleigh J.A., Thrall D.E. Quantification of CCI-103F labeling heterogeneity in canine solid tumors. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;655-662.
7. Cline J.M., Thrall D.E., Rosner G.L., Raleigh J.A. Distribution of the hypoxia marker CCI-103F in canine tumors. Int. J. Radiat. Oncol. Biol. Phys. 28:1994;921-933.
8. Delides G., Venizelos J., Revesz L. Vascularization and curability of stage III and IV nasopharyngeal tumors. J. Cancer Res. Clin. Oncol. 114:1988;321-323.
9. Dewhirst M.W. Concepts of oxygen transport at the microcirculatory level. Semin. Radiat. Oncol. 8:1998;143-150.
10. Evans S.M., Jenkins W.T., Joiner B., Lord E.M., Koch C.J. 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors. Cancer Res. 56:1996;405-411.
11. Fenton B.M., Paoni S.F., Lee J., Koch C.J., Lord E.M. Quantification of tumour vasculature and hypoxia by immunohistochemical staining and HbO2 saturation measurements. Br. J. Cancer. 79:1999;464-471.
12. Gasparini G., Weidner N., Bevilacqua P., et al. Tumor microvessel density, p53 expression, tumor size, and peritrumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J. Clin. Oncol. 12:1994;454-466.
13. Herlyn M., Clark W.H., Rodeck U., et al. Biology of tumor progession in human melanocytes. Lab. Invest. 56:1987;461-474.
14. Hockel M., Schlenger K., Aral B., et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:1996;4509-4515.
15. Hodgkiss R.J., Jones G., Long A., et al. Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection. Br. J. Cancer. 63:1991;119-125.
16. Horak E., Leek R., Klenk N., et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet. 340:1992;1120-1124.
17. Kennedy A.S., Raleigh J.A., Perez G.M., et al. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;897-905.
18. Kolstad P. Intercapillary distance, oxygen tension and local recurrence in cervix cancer. Scand. J. Lab. Invest. 106S:1968;145-157.
19. Lauk S., Skates S., Goodman M., Suit H.D. A morphometric study of the vascularity of oral squamous cell carcinomas and its relation to outcome of radiation therapy. Eur. J. Cancer Clin. Oncol. 25:1989;1431-1440.
20. Marson L.P., Kurian K.M., Miller W.R., Dixon J.M. Reproducibility of microvessel counts in breast cancer specimens. Br. J. Cancer. 81:1999;1088-1093.
21. Nordsmark M., Overgaard M., Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother. Oncol. 41:1996;31-39.
22. Overgaard J. Importance of tumor hypoxia in radiotherapy. A meta-analysis of controlled clinical trials. Radiother. Oncol. 24:1992;64-64.
23. Raleigh J.A., Miller G.G., Franko A.J., et al. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. Br. J. Cancer. 56:1987;395-400.
24. Revesz L., Siracka E., Siracky J., Delides G., Pavlaki K. Variation of vascular density within and between tumors of the uterine cervix and its predictive value for radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 16:1989;1161-1163.
25. Saclarides T.J., Speziale N.J., Drab E., Szeluga D.J., Rubin D.B. Tumor angiogenesis and rectal carcinoma. Dis. Colon Rectum. 37:1994;921-926.
26. Schlingemann R.O., Rietveld F.J.R., Kwaspen F., et al. Differential expression of markers for endothelial cells, pericytes and basal lamina in the microvasculature of tumors and granulation tissue. Am. J. Pathol. 138:1991;1335-1347.
27. Siracka E., Revesz L., Kovac R., Siracky J. Vascular density in carcinoma of the uterine cervix and its predictive value for radiotherapy. Int. J. Cancer. 41:1988;819-822.
28. Thomlinson R.H., Gray L.H. The histological structure of some human lung cancers as the possible implications for radiotherapy. Br. J. Cancer. 9:1955;539-539.
29. Van Heusden J., De Jong P., Ramaekers F., et al. Fluorescein-labeled tyramide strongly enhances the detection of low bromodeoxyuridine incoporation levels. J. Histochem. Cytochem. 45:1997;315-319.
30. Vermeulen P.B., Verhoeven D., Fierens H., et al. Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study. Br. J. Cancer. 71:1995;340-343.
31. Webster L., Hodgkiss R.J., Wilson G.D. Cell cycle distribution of hypoxia and progression of hypoxic tumour cells in vivo. Br. J. Cancer. 77:1998;227-234.
32. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res. Treat. 36:1995;169-180.
33. Zatterstrom U.K., Brun E., Willen R., Kjellen E., Wennerberg J. Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head Neck. 17:1995;312-318.